Insider trades

Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.

4,839 companies covered, latest filing Oct 23.

$79.2M bought by 61 insiders at 47 companies
$239M sold by 49 insiders outside a trading plan
$2.5B sold by 203 insiders under 10b5-1 plans
10 companies where two or more insiders bought (30 days)

Biggest buys

Past week, each insider's filings added up.

CRBGCorebridge Financial

Life Insurance Co Nippon10% owner

1,430,631 shares at $34.37 Oct 15–21, 5 filings +1.1% to stake 2 superinvestors bought in Q2

$49.2M
DOLEDole PLC

Pale Fire Capital SE10% owner, +4 joint filers

648,356 shares at $13.19 Oct 20–22 +6.7% to stake

$8.6M
APLDApplied Digital

Jason Gechen ZhangPresident

300,000 shares at $18.86 Oct 16 +12% to stake 5 superinvestors bought in Q2

$5.7M
RENTRent the Runway

STORY3 Capital Partners, LLCDirector, +3 joint filers

632,922 shares at $3.55 Oct 21 +15% to stake

$2.2M
RENTRent the Runway

CHS US Investments LLC10% owner, +4 joint filers

458,245 shares at $3.55 Oct 21 +2% to stake

$1.6M
FBKFB Financial

Orrin H Ingram IIDirector

29,081 shares at $52.88 Oct 20 +31% to stake

$1.5M
TENXTenax Therapeutics

ADAR1 Capital Management, LLC10% owner, +1 joint filer

922,849 shares at $1.59 Oct 19–21 +14% to stake

$1.5M
APLDApplied Digital

Wes CumminsCEO

55,803 shares at $18.04 Oct 16 +1% to stake 5 superinvestors bought in Q2

$1M
RAPPRapport Therapeutics

Steven M PaulDirector

35,714 shares at $27.28 Oct 22 +86% to stake

$974K
SNESSenesTech

Glenbrook Capital Management10% owner

1,087,679 shares at $0.7200 Oct 15–22, 2 filings

$781K

Biggest sales

Past week, each insider's filings added up. Planned sales are marked.

IHTInnSuites Hospitality Trust

James F WirthCEO

43,111 shares at $46,654.38 Oct 20 0.5% of stake Planned sale (10b5-1)

$2B
SNOWSnowflake

Frank SlootmanDirector

300,000 shares at $316.43 Oct 19 94% of stake Planned sale (10b5-1)

$94.9M
TALOTalos Energy

Empresarial De Capitales S.a. De C.v. Control10% owner

4,893,590 shares at $17.55 Oct 15–19, 2 filings 17% of stake

$85.9M
TRVTravelers

Alan D SchnitzerCEO

88,900 shares at $396.77 Oct 21 23% of stake

$35.3M
PATHUiPath

Daniel DinesCEO

2,500,000 shares at $13.23 Oct 15–16 7.9% of stake Planned sale (10b5-1)

$33.1M
UTHRUnited Therapeutics

Martine A RothblattCEO

47,500 shares at $555.06 Oct 16–22, 5 filings 13% of stake Planned sale (10b5-1)

$26.4M
MUMicron Technology

Scott J DeboerPres. & Chief Tech & Prod Offr

28,545 shares at $900.00 Oct 16 16% of stake Planned sale (10b5-1)

$25.7M
ALMRAlamar Biosciences

Qiming Corporate GP VI, Ltd.10% owner, +6 joint filers

733,811 shares at $28.64 Oct 15–22, 3 filings 29% of stake

$21M
SNOWSnowflake

Benoit DagevilleDirector

50,000 shares at $321.74 Oct 21 2.1% of stake Planned sale (10b5-1)

$16.1M
LINDLindblad Expeditions

Sven-Olof LindbladDirector

403,674 shares at $35.31 Oct 16–22, 2 filings 3.8% of stake Planned sale (10b5-1)

$14.3M

Cluster buying

Companies where two or more insiders bought on the open market in the last 30 days, most buyers first

TSMTaiwan Semiconductor 19 insiders, $80K

Che-Chia Wei CEO, Yuh-Jier Mii COO, Yung-Pei Chin COO, Yung-Chin Hou COO, +15 more

Latest buy Oct 7 19 executives 20 superinvestors sold in Q2
SPGSimon Property Group 11 insiders, $461K

Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more

Latest buy Sep 30
FULH. B. Fuller 9 insiders, $1.1M

R Jeffrey Bailly Director, Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, +5 more

Latest buy Oct 16 1 executive 1 superinvestor bought in Q2
RAPPRapport Therapeutics 6 insiders, $1.7M

Steven M Paul Director, John Maraganore Director, Troy A. Ignelzi CFO, Wendy B. Young Director, +2 more

Latest buy Oct 23 1 executive
ATCHAtlasClear 5 insiders, $163K

Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more

Latest buy Sep 25 3 executives
RGCORGC Resources 5 insiders, $85K

John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more

Latest buy Oct 1 3 executives
WVVIWillamette Valley Vineyards 5 insiders, $75K

Michael Jordan Osborn CEO, John Walter Hazlett CFO, Gregory William Voorhies Director, James W Bernau President, +1 more

Latest buy Oct 12 3 executives
MPBMid Penn Bancorp 5 insiders, $25K

Matthew G De Soto Director, Albert J. Evans Director, Joel L. Frank Director, Theodore W Mowery Director, +1 more

Latest buy Sep 30
DXDynex Capital 4 insiders, $245K

Smriti Laxman Popenoe CEO, Byron L Boston CEO, Terrence John Connelly Jr. Chief Investment Officer, Michael Andrew Sartori CFO

Latest buy Oct 20 4 executives
ANIXAnixa Biosciences 4 insiders, $203K

Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director

Latest buy Oct 22 2 executives

GEVO insider trades

Every open-market buy and sale in GEVO, one row per filing, newest first

GEVO page

All Buys Sales

Everyone CEOs CFOs Executives Directors 10% owners

Any size $100K+ $1M+ $10M+

Hide planned sales

Insider

Stock

Trade

Value

Traded, filed
Patrick R. Gruber Director

GEVOGevo Inc.

Planned sale

$5,671 3,333 shares at $1.70 0.1% of stake

Traded Sep 3 Filed Sep 4

↗
David Michael Kettner Chief Legal & Emrg Biz Officer

GEVOGevo Inc.

Buy

$19K 12,500 shares at $1.55 +4.7% to stake

Traded Aug 21 Filed Aug 24

↗
James J Barber Director

GEVOGevo Inc.

Buy

$77K 50,000 shares at $1.54 +71% to stake

Traded Aug 21 Filed Aug 24

↗
Patrick R. Gruber Director

GEVOGevo Inc.

Planned sale

$374K 247,642 shares at $1.51 6.9% of stake

Traded Aug 6 Filed Aug 7

↗
Oluwagbemileke Yusuf Agiri CFO

GEVOGevo Inc.

Planned sale

$28K 18,223 shares at $1.54 3.7% of stake

Traded Aug 6 Filed Aug 7

↗
Patrick R. Gruber Director

GEVOGevo Inc.

Planned sale

$221K 157,563 shares at $1.40 4.2% of stake

Traded Jun 12 Filed Jun 15

↗
Oluwagbemileke Yusuf Agiri CFO

GEVOGevo Inc.

Planned sale

$88K 63,028 shares at $1.40 11% of stake

Traded Jun 12 Filed Jun 15

↗
Oluwagbemileke Yusuf Agiri CFO

GEVOGevo Inc.

Planned sale

$57K 31,958 shares at $1.77 5.5% of stake

Traded May 27 Filed May 29

↗
Andrew Shafer Chief Cust Mkt & Brnd Officer

GEVOGevo Inc.

Planned sale

$11K 5,550 shares at $2.00 2% of stake

Traded May 1 Filed May 1

↗
Andrew Shafer Chief Cust Mkt & Brnd Officer

GEVOGevo Inc.

Planned sale

$15K 5,550 shares at $2.71 2% of stake

Traded Apr 1 Filed Apr 2

↗
Christopher Michael Ryan COO

GEVOGevo Inc.

Planned sale

$364K 129,797 shares at $2.80 8.5% of stake

Traded Mar 30–31 Filed Apr 1

↗
Gary W. Mize Director

GEVOGevo Inc.

Sale

$250K 107,100 shares at $2.34 28% of stake

Traded Mar 12 Filed Mar 12

↗
Andrew Shafer Chief Cust Mkt & Brnd Officer

GEVOGevo Inc.

Planned sale

$12K 5,550 shares at $2.21 2% of stake

Traded Mar 10 Filed Mar 12

↗
Lindsay Clinton Fitzgerald Chief Public Affairs Officer

GEVOGevo Inc.

Planned sale

$50K 20,000 shares at $2.51 8.6% of stake

Traded Mar 12 Filed Mar 12

↗
Andrew Shafer Chief Cust Mkt & Brnd Officer

GEVOGevo Inc.

Planned sale

$9,940 5,000 shares at $1.99 1.8% of stake

Traded Jan 20 Filed Jan 21

↗
Andrew Shafer Chief Cust Mkt & Brnd Officer

GEVOGevo Inc.

Planned sale

$11K 5,000 shares at $2.19 1.8% of stake

Traded Dec 22, 2025 Filed Dec 23, 2025

↗
Oluwagbemileke Yusuf Agiri CFO

GEVOGevo Inc.

Sale

$169K 73,284 shares at $2.31 21% of stake

Traded Dec 5, 2025 Filed Dec 8, 2025

↗
Andrew Shafer Chief Cust Mkt & Brnd Officer

GEVOGevo Inc.

Planned sale

$9,937 5,000 shares at $1.99 1.7% of stake

Traded Nov 20, 2025 Filed Nov 21, 2025

↗
Carol Jane Battershell Director

GEVOGevo Inc.

Sale

$153K 75,597 shares at $2.02 21% of stake

Traded Nov 13, 2025 Filed Nov 14, 2025

↗
Andrew Shafer Chief Cust Mkt & Brnd Officer

GEVOGevo Inc.

Planned sale

$13K 5,000 shares at $2.53 1.6% of stake

Traded Oct 20, 2025 Filed Oct 23, 2025

↗
Christopher Michael Ryan COO

GEVOGevo Inc.

Planned sale

$282K 100,000 shares at $2.82 6.1% of stake

Traded Oct 15, 2025 Filed Oct 15, 2025

↗
Angelo Amorelli Director

GEVOGevo Inc.

Planned sale

$250K 100,000 shares at $2.50 97% of stake

Traded Oct 14, 2025 Filed Oct 15, 2025

↗

About this data

Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
We cover the 4,839 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.